Mr. Jeremy Daniel biography
Jeremy Daniel is the Chief Financial Officer at H-CYTE.
What is the salary of Mr Daniel?
As the Chief Financial Officer of H-CYTE, the total compensation of Mr Daniel at H-CYTE is $200,000. There are 2 executives at H-CYTE getting paid more, with William Horne having the highest compensation of $2,372,870.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
How old is Mr Daniel?
Mr Daniel is 45, he's been the Chief Financial Officer of H-CYTE since . There are 6 older and 2 younger executives at H-CYTE. The oldest executive at H-CYTE, Inc. is Raymond Monteleone, 72, who is the Director.
What's Mr Daniel's mailing address?
Jeremy's mailing address filed with the SEC is 201 E KENNEDY BLVD, SUITE 700, , TAMPA,, FL, 33606.
Insiders trading at H-CYTE
Over the last 6 years, insiders at H-CYTE have traded over $0 worth of H-CYTE stock and bought 60,000 units worth $8,050 . The most active insiders traders include Todd Rfwhc Holdings, Llc Wa..., J Rex Iiifwhc Holdings, Llc... a Michael Yurkowsky. On average, H-CYTE executives and independent directors trade stock every 286 days with the average trade being worth of $10,590,590. The most recent stock trade was executed by J Rex Iiifwhc Holdings, Llc... on 23 February 2022, trading 693,477 units of HCYT stock currently worth $6,935.
What does H-CYTE do?
H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute biologics for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.
What does H-CYTE's logo look like?
H-CYTE executives and stock owners
H-CYTE executives and other stock owners filed with the SEC include:
-
William Horne,
Chairman of the Board -
Robert Greif,
Pres -
Jeremy Daniel,
Chief Financial Officer -
Jeremy Daniel,
Chief Financial Officer -
Michael W. Yurkowsky,
CEO & Director -
Michael Yurkowsky,
Director -
Raymond Monteleone,
Director -
Robert Greifas,
President, Chief Executive Officer -
Dr. Tanya Rhodes Ph.D.,
Chief Technology Officer -
Jeffery Wright CPA, CPA,
Controller & Principal Accounting Officer -
J Rex Iiifwhc Holdings, Llc...,
-
Todd Rfwhc Holdings, Llc Wa...,
-
Frederick Jcfrs Investments...,
-
Robert Smith Greif,
Chief Executive Officer -
Todd Rfwhc Bridge, Llc Wagner,